NCT00193427 - Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

November 30, 2008

Study Completion Date

December 31, 2008

Conditions

Lung Cancer

Interventions

DRUG

Docetaxel

30mg/m2 administered on days 1 and 8, 21-cycle days, 3 cycles

DRUG

Gemcitabine

1000 mg/m2 administered by 30-minute IV infusion on day 1 and 8, 21-cycle days, 3 cycles

DRUG

Carboplatin

AUC = 1.5 weekly x 7

RADIATION

Radiation

To 63 Gy

Trial Locations (1)

Tennessee Oncology, PLLC, Nashville